These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35861017)

  • 1. Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an
    De Stefano V; Larocca A; Carpenedo M; Cavo M; Di Raimondo F; Falanga A; Offidani M; Petrucci MT; Ruggeri M; Santi RM; Barosi G
    Haematologica; 2022 Nov; 107(11):2536-2547. PubMed ID: 35861017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of venous thromboembolic events occurring in myeloma patients treated with second-generation novel agents.
    Santoro M; Romano A; Mancuso S; Siragusa S; DI Raimondo F; Martinelli G; Cerchione C
    Panminerva Med; 2021 Mar; 63(1):1-6. PubMed ID: 32955183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of infectious risk of daratumumab therapy in multiple myeloma: A consensus-based position paper from an ad hoc Italian expert panel.
    Girmenia C; Cavo M; Corso A; Di Raimondo F; Musto P; Offidani M; Petrucci MT; Rosato A; Barosi G
    Crit Rev Oncol Hematol; 2022 Apr; 172():103623. PubMed ID: 35151867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations.
    Girmenia C; Cavo M; Offidani M; Scaglione F; Corso A; Di Raimondo F; Musto P; Petrucci MT; Barosi G
    Blood Rev; 2019 Mar; 34():84-94. PubMed ID: 30683446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations.
    Swan D; Rocci A; Bradbury C; Thachil J
    Br J Haematol; 2018 Nov; 183(4):538-556. PubMed ID: 30450656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?
    Lapietra G; Serrao A; Fazio F; Petrucci MT; Chistolini A
    J Thromb Thrombolysis; 2021 Aug; 52(2):584-589. PubMed ID: 33417149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study.
    Leclerc V; Karlin L; Herledan C; Marchal L; Baudouin A; Gouraud A; Caffin AG; Larbre V; Lazareth A; Bachy E; Salles G; Ghesquières H; Rioufol C; Ranchon F
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):975-984. PubMed ID: 34143239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19: An American College of Chest Physicians Expert Panel Report.
    Potpara T; Angiolillo DJ; Bikdeli B; Capodanno D; Cole O; Yataco AC; Dan GA; Harrison S; Iaccarino JM; Moores LK; Ntaios G; Lip GYH
    Chest; 2023 Dec; 164(6):1531-1550. PubMed ID: 37392958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.
    Al-Hameed F; Al-Dorzi HM; AlMomen A; Algahtani F; AlZahrani H; AlSaleh K; AlSheef M; Owaidah T; Alhazzani W; Neumann I; Wiercioch W; Brozek J; Schünemann H; Akl EA
    Ann Saudi Med; 2015; 35(2):95-106. PubMed ID: 26336014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloma and thrombotic complications.
    Tzoran I; Brenner B; Hoffman R
    Minerva Med; 2013 Apr; 104(2):155-60. PubMed ID: 23514991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboprophylaxis in multiple myeloma.
    Thalambedu N; Al Hadidi S
    Leuk Lymphoma; 2022 Dec; 63(12):2807-2815. PubMed ID: 35759648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboprophylaxis prescribing and thrombotic event rates in multiple myeloma patients treated with lenalidomide or thalidomide at a specialist cancer hospital.
    Alexander M; Teoh KC; Lingaratnam S; Kirsa S; Mellor JD
    Asia Pac J Clin Oncol; 2013 Jun; 9(2):169-75. PubMed ID: 22998589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboprophylaxis in multiple myeloma patients treated with lenalidomide - A systematic review.
    Al-Ani F; Bermejo JM; Mateos MV; Louzada M
    Thromb Res; 2016 May; 141():84-90. PubMed ID: 26986753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk and management of thrombosis in multiple myeloma.
    Leebeek FW; Kruip MJ; Sonneveld P
    Thromb Res; 2012 Apr; 129 Suppl 1():S88-92. PubMed ID: 22682142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism risk with contemporary lenalidomide-based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta-analysis.
    Chakraborty R; Bin Riaz I; Malik SU; Marneni N; Mejia Garcia A; Anwer F; Khorana AA; Rajkumar SV; Kumar S; Murad MH; Wang Z; Khan SU; Majhail NS
    Cancer; 2020 Apr; 126(8):1640-1650. PubMed ID: 31913498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis in multiple myeloma: mechanisms, risk assessment and management.
    Jarchowsky O; Avnery O; Ellis MH
    Leuk Lymphoma; 2023 Dec; 64(12):1905-1913. PubMed ID: 37584485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Newly diagnosed multiple myeloma: Do we need to propose thromboprophylaxis?].
    Chalayer E; Augeul-Meunier K; Tardy-Poncet B; Cathebras P; Guyotat D; Tardy B
    Rev Med Interne; 2012 Dec; 33(12):693-6. PubMed ID: 23067869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis.
    Takaishi K; Tsukamoto S; Ohwada C; Takeuchi M; Kawasaki Y; Nagai Y; Mishina T; Yamazaki M; Isshiki Y; Kayamori K; Kimura K; Hino Y; Oshima-Hasegawa N; Mitsukawa S; Takeda Y; Mimura N; Iseki T; Nakaseko C; Sakaida E
    J Thromb Thrombolysis; 2019 Jul; 48(1):141-148. PubMed ID: 30673940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on thrombotic events associated with multiple myeloma.
    Fotiou D; Gavriatopoulou M; Ntanasis-Stathopoulos I; Migkou M; Dimopoulos MA; Terpos E
    Expert Rev Hematol; 2019 May; 12(5):355-365. PubMed ID: 30957573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.